Biocross

About:

Biocross is a biotechnology company develops blood tests for the diagnosis of Alzheimer’s disease.

Top Investors: Centre for the Development of Industrial Technology (CDTI), CRB Inverbío, SODICAL

Description:

Biocross, S.L., a biotechnology company, develops blood tests for the diagnosis of Alzheimer’s diseases to neurologists.

Total Funding Amount:

450000 EUR

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Boecillo, Castilla y Leon, Spain

Founded Date:

2005-01-01

Founders:

Number of Employees:

11-50

Last Funding Date:

2021-09-01

IPO Status:

Private

Industries: